Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience
- PMID: 28280618
- PMCID: PMC5334039
- DOI: 10.21037/jgo.2016.12.08
Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience
Abstract
Background: The gastroenteropancreatic neuroendocrine tumors (GEPNET) have a characteristic histologic appearance unrelated of the exact site of origin. However the behavior of these tumors are different in each of these sites. In this article we study the clinicopathological features of GEPNET. These tumors were classified and graded according to WHO 2010 criteria. The immunohistochemical (IHC) features were evaluated and the grade of the tumor was correlated with Ki67.
Methods: A total of 40 cases of GEPNET diagnosed on biopsies as well as resected specimens were analyzed from January 2012 to June 2015.
Results: There were 28 resected specimens and 12 biopsies. Majority of the gastric neuroendocrine tumors (NET) showed classic morphology of cells arranged in islands. There were 3 cases each of grade 1 and grade 2 and one was diagnosed as mixed adenoneuroendocrine carcinoma (MANEC). All the duodenal NET were well differentiated (grade 1). There were 8 cases in colon and rectum, of which 4 cases were grade 3 and 3 cases were grade 2. Majority of the pancreatic tumors were grade 1. The mean mitotic count along with ki67 had good correlation in NET of stomach, duodenum colon and rectum.
Conclusions: The most common site was small intestine followed by pancreas. Majority of the tumors were NET G1. Tumors from colorectal region were mostly NEC G3. There was a strong correlation by spearman correlation analysis between Ki67 and mitotic count and moderate correlation between ki67 and tumor grade as well as mitotic rate and tumor grade. Ki67 was helpful in grading these tumors.
Keywords: Ki67; Neuroendocrine tumors (NET); grade.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures







Similar articles
-
Clinicopathologic profile of gastroenteropancreatic neuroendocrine neoplasms in a referral center of South India.Int J Clin Exp Pathol. 2022 May 15;15(5):225-232. eCollection 2022. Int J Clin Exp Pathol. 2022. PMID: 35698638 Free PMC article.
-
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.Am J Surg Pathol. 2016 Sep;40(9):1192-202. doi: 10.1097/PAS.0000000000000662. Am J Surg Pathol. 2016. PMID: 27259015 Free PMC article.
-
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408. Am J Surg Pathol. 2015. PMID: 25723112 Free PMC article.
-
Early Gastroenteropancreatic Neuroendocrine Tumors: Endoscopic Therapy and Surveillance.Visc Med. 2017 Oct;33(5):332-338. doi: 10.1159/000459404. Epub 2017 Oct 10. Visc Med. 2017. PMID: 29177161 Free PMC article. Review.
-
Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.Oncologist. 2016 Oct;21(10):1191-1199. doi: 10.1634/theoncologist.2015-0476. Epub 2016 Jul 8. Oncologist. 2016. PMID: 27401895 Free PMC article. Review.
Cited by
-
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin.Sci Rep. 2019 Mar 13;9(1):4339. doi: 10.1038/s41598-019-39607-2. Sci Rep. 2019. PMID: 30867449 Free PMC article.
-
Combination of laparoscopy and endoscopy as an option for treatment patients with gastric neuroendocrine tumors.J Surg Case Rep. 2019 Jan 31;2019(1):rjz007. doi: 10.1093/jscr/rjz007. eCollection 2019 Jan. J Surg Case Rep. 2019. PMID: 30792837 Free PMC article.
-
Clinicopathological Features of Neuroendocrine Tumors in Gastroenteropancreatic Tract: A Single Center Study.Cureus. 2022 Jul 28;14(7):e27384. doi: 10.7759/cureus.27384. eCollection 2022 Jul. Cureus. 2022. PMID: 36046310 Free PMC article.
-
Histopathological features of gastrointestinal and pancreatic neuroendocrine neoplasms: An 11-year retrospective study from a tertiary center in Saudi Arabia.Saudi Med J. 2025 Jul;46(7):761-767. doi: 10.15537/smj.2025.46.7.20250313. Saudi Med J. 2025. PMID: 40628434 Free PMC article.
-
Clinicopathologic profile of gastroenteropancreatic neuroendocrine neoplasms in a referral center of South India.Int J Clin Exp Pathol. 2022 May 15;15(5):225-232. eCollection 2022. Int J Clin Exp Pathol. 2022. PMID: 35698638 Free PMC article.
References
-
- Amarapurkar DN, Juneja MP, Patel ND, et al. A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract. Trop Gastroenterol 2010;31:101-4. - PubMed
-
- Rindi G, Arnold R, Bosman FT. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, et al. editors. WHO classification of tumors of the digestive system. Lyon: International Agency for Research on Cancer (IARC), 2010:13-4.
LinkOut - more resources
Full Text Sources
Other Literature Sources